Transcription of QRD Human Product Information Template
{{id}} {{{paragraph}}}
Example: barber
QRD Human Product Information Template
1 Version 10, 02/2016 , 06/2015 ANNEX I SUMMARY OF Product CHARACTERISTICS [NOTE: the following are those items of Information required by Article 11 of Directive 2001/83/EC, as amended, and current practice in the centralised procedure. In the case of advanced therapy medicinal products, these items are listed in Annex II of Regulation (EC) 1394/2007. For the full Information to be included in each section, please refer to the Guideline on Summary of Product Characteristics as published on the Website of the European Commission in the Notice to Applicants, Volume 2C: This guidance should also be read in conjunction with other relevant guidelines that can be found on the European Medicines Agency website ( QRD Convention to be followed for the EMA-QRD templates : ).]
2 - English language version: immediately after adoption of the opinion. - All other language versions: at the latest 25 days after adoption of the opinion (i.e. at the
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
DECENTRALISED PROCEDURE MEMBER STATES’, DECENTRALISED PROCEDURE MEMBER STATES’ STANDARD, Procedure, Public Assessment Report Decentralised Procedure, Public Assessment Report . Decentralised Procedure, Decentralised Procedure, FLOW CHART OF THE DECENTRALISED, FLOW CHART OF THE DECENTRALISED PROCEDURE, All About Regulatory Affairs, Member States, Commission Regulation, Quick Response (QR) codes in the labelling and, Decentralised, EU regulatory framework and the role, REGISTER OF MEDICINAL, Register of medicinal products - frequently asked questions